VR Logo

Renovacor Inc. (RCOR) download report


Healthcare | Biotechnology & Pharma Research

Renovacor Inc. (RCOR) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases.

IPO Date: 22-Jun-2020

Chairman, Pres & CEO: Dr. Magdalene K. Cook M.D.

Chief Scientific Officer: Dr. Matthew Killeen Ph.D.

Listing: NYSE: RCOR

Country: United States

Headquarters: Greenwich, CT

Website: https://www.renovacor.com

Key Facts

Market cap: $31.08 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-2.60 Mln

Cash: $70.08 Mln

Total Debt: $0.00 Mln

Insider's Holding: 52.17%

Liquidity: Low

52 Week range: $1.34 - 10.74

Shares outstanding: 17,267,400

Stock Performance

Time Period Renovacor (RCOR) S&P BSE Sensex S&P Small-Cap 600
YTD-74.03-8.97-19.67
1 month2.04-3.38-9.84
3 months-53.49-7.93-15.05
1 Year-79.920.55-18.10
3 Years--10.415.71
5 Years--11.455.53
10 Years--12.0510.04
As on 29-Jun-2022
Year Renovacor (RCOR) S&P Small-Cap 600 S&P BSE Sensex
2021-24.5125.2721.99